Low levels of HLA-specific antibody: relevance, detection, and treatment.
Zachary
A A
AA
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ratner
L E
LE
Leffell
M S
MS
D000208:Acute Disease; D000906:Antibodies / Q000627:therapeutic use*; D000918:Antibody Specificity / Q000276:immunology; D003131:Combined Modality Therapy; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D010956:Plasmapheresis
D000906:Antibodies; D006680:HLA Antigens; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; C045781:cytomegalovirus-specific hyperimmune globulin